Skip to main content
Equibles

Hudson Bay Capital Management LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1393825 STAMFORD, CT
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,899,160
+$732,351 QoQ
Shares Held
1,364,000
-7.2% QoQ
Ownership
0.806%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#19
of 237 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. VIR ranks #7 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 390,440 $193,943,261
2 BMRN
Biomarin Pharmaceutical Inc
 825,002 $47,206,614
3 ALNY
Alnylam Pharmaceuticals, Inc.
 148,720 $44,769,181
4 BNTX
BioNTech SE
 260,000 $24,193,000
5 IMCR
Immunocore Holdings plc
 590,000 $18,732,500
6 TECH
BIO-TECHNE Corp
 200,000 $14,130,000
7 VIR
Vir Biotechnology, Inc.
This page 		1,364,000 $13,899,160
8 PTCT
Ptc Therapeutics, Inc.
 159,778 $13,033,091

All Filings in VIR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,899,160 1,364,000
2026-03-31 $13,166,809 1,469,510
2025-12-31 $7,989,750 1,325,000
2025-09-30 $5,206,846 911,882
2025-06-30 $3,507,840 696,000
2025-03-31 $3,832,401 591,420
2024-12-31 $6,238,067 849,873
2024-09-30 $3,956,532 528,242
2024-06-30 $3,782,500 425,000
2024-03-31 $2,887,050 285,000
2023-12-31 $2,917,400 290,000
2023-09-30 $1,944,275 207,500
2023-06-30 $245,300 10,000